Uri Weinberg, Chief Science Officer at NovoCure Ltd (NVCR), sold 24,000 shares at $103.35 ($2.5M) on 2020-09-25, disclosed to the SEC on 2020-09-28.
Open-market sale of $2.5M NVCR by Chief Science Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.35 | 6,500 | $672K | 27.1% |
| 2 | $103.35 | 8,750 | $904K | 36.5% |
| 3 | $103.35 | 8,750 | $904K | 36.5% |
| Total | $103.35 avg | 24,000 | $2.5M | 100% |
| Filing → |
| NVCR | SELL | 2025-03-04 | $5K | — | Filing → |
| NVCR | SELL | 2025-03-03 | $168K | — | Filing → |
| NVCR | SELL | 2023-01-09 | $946K | — | Filing → |